Clinical trial
ITV Extension Study
NCT00332930 · Kirby Institute, Other · Completed
Key facts
| NCT number | NCT00332930 |
|---|---|
| Title | ITV Extension Study |
| Official title | An Extension Study to Protocol VIR-NCHR-01 to Assess the Antiretrovirological Properties of a Therapeutic HIV Vaccine Candidate Based on Recombinant Fowlpox Virus (rFPV) (ITV Extension Study) |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | The University of New South Wales Virax Pty. Ltd, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Biological |
| Interventions | recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens, HIV gag-pol antigens and interferon-gamma (IFN-y) |
| Enrollment | 35 |
| Start date | Sep 1, 2002 |
| Completion | Sep 1, 2003 |
| First posted | Jun 2, 2006 |
| Last update posted | Feb 27, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: